CIVKX
Price
$21.00
Change
+$0.58 (+2.84%)
Updated
Feb 3 closing price
Net Assets
2.57B
RERAX
Price
$59.26
Change
-$1.78 (-2.92%)
Updated
Feb 3 closing price
Net Assets
134.63B
Interact to see
Advertisement

CIVKX vs RERAX

Header iconCIVKX vs RERAX Comparison
Open Charts CIVKX vs RERAXBanner chart's image
American Funds International Vntg 529F-1
Price$21.00
Change+$0.58 (+2.84%)
VolumeN/A
Net Assets2.57B
American Funds EUPAC R1
Price$59.26
Change-$1.78 (-2.92%)
VolumeN/A
Net Assets134.63B
CIVKX vs RERAX Comparison Chart in %
View a ticker or compare two or three
VS
CIVKX vs. RERAX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIVKX is a StrongBuy and RERAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 135B vs. CIVKX (2.57B). RERAX pays higher dividends than CIVKX: RERAX (2.30) vs CIVKX (1.29). CIVKX was incepted earlier than RERAX: CIVKX (6 years) vs RERAX (24 years). RERAX (1.57) is less costly to investors than CIVKX (0.97). RERAX is a more actively managed with annual turnover of: 35.00 vs. CIVKX (32.00). CIVKX (250) and RERAX (250) have matching initial minimum investment requirements. CIVKX annual gain was more profitable for investors over the last year : 25.87 vs. RERAX (16.59). CIVKX return over 5 years is better than : 34.07 vs. RERAX (-8.55).
CIVKXRERAXCIVKX / RERAX
Total Expense Ratio0.961.5761%
Annual Report Gross Expense Ratio0.971.5762%
Fund Existence6 years24 years-
Gain YTD3.9605.57671%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.57B135B2%
Annual Yield % from dividends1.292.3056%
Returns for 1 year25.8716.59156%
Returns for 3 years40.8921.43191%
Returns for 5 years34.07-8.55-399%
Returns for 10 yearsN/A56.65-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EEMEX10.940.09
+0.83%
MFS Emerging Markets Equity Research R2
OLVCX21.290.01
+0.05%
JPMorgan Large Cap Value C
BSGPX1.79N/A
N/A
Baillie Gifford Developed EAFE All Cap I
MUIGX18.19-0.16
-0.87%
Nationwide BNY Mellon Dyn US Core R6
JFCCX31.06-0.63
-1.99%
JHancock Fundamental All Cap Core C